New Research Offers Hope To Mesothelioma Patients
Thursday, March 12th, 2009In a recent study announced in February, researchers generated altered immune cells that were able to shrink — and in some cases wipe out — large tumors in mice.
The scientific research provides a ray of hope in the fight against Mesothelioma.
“Based on the size of the tumors and the number of cells administered, we estimate that one mesothelin-targeted T cell was able to kill about 40 tumor cells,” said study leader Carl H. June, M.D., Professor of Pathology and Laboratory Medicine and director of Translational Research at Penn’s Abramson Cancer Center.
“This finding indicates that small doses of these cells may have potential in treating patients with large tumors,” Dr. June said in a press release.
Clinical trials are being developed to investigate this approach in patients with mesothelioma and ovarian cancer.
Please explore our website for more detailed information on Mesothelioma, including diagnosis, treatment, clinical trials, doctors and hospitals treating the disease, and your legal options.
